• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法综述。

Review of photodynamic therapy.

作者信息

Awan M A, Tarin S A

机构信息

Wolverhampton Eye Infirmary, Wolverhampton, UK.

出版信息

Surgeon. 2006 Aug;4(4):231-6. doi: 10.1016/s1479-666x(06)80065-x.

DOI:10.1016/s1479-666x(06)80065-x
PMID:16892841
Abstract

INTRODUCTION

Photodynamic Therapy (PDT) is an emerging treatment for a variety of conditions including ocular and extra ocular diseases. The porphyrins have been used extensively, as dyes, which are laser-activated to achieve desired clinical effects. Commonly used agents are verteporfin and porfimer sodium.

METHODS

We performed a literature search of the PubMed database using the medical search headings: photodynamic therapy, photosensitizer verteporfin, visudyne, porfimer sodium and photofrin. We also performed a manual search using references from these articles, review articles and manufacturers' product monographs.

RESULTS

Verteporfin and porfimer sodium are commonly used photosensitizing agents with their wide applications in different fields of medicine. Both have well established safety profiles. They are most commonly used in wet age-related macular degeneration, gastrointestinal diseases and bronchial cancers.

CONCLUSION

PDT is a well established treatment entity in ophthalmology and other medical fields. In ophthalmology, it has rekindled interest and hopes in the common yet sight-threatening problem of age-related macular degeneration (AMD). This problem is still considered to be a serious issue as far as management is concerned. However in selective cases of AMD, it has shown success in restoring sight, especially in the 'classic' form of the disease. PDT is also being used to treat a range of solid cancers and non malignant conditions

摘要

引言

光动力疗法(PDT)是一种新兴的治疗方法,可用于治疗包括眼科和眼外疾病在内的多种病症。卟啉作为染料已被广泛使用,其通过激光激活以达到预期的临床效果。常用的药物是维替泊芬和卟吩姆钠。

方法

我们使用医学检索词“光动力疗法”“光敏剂维替泊芬”“维速达尔”“卟吩姆钠”和“光卟啉”在PubMed数据库中进行文献检索。我们还使用这些文章的参考文献、综述文章和制造商的产品说明书进行了人工检索。

结果

维替泊芬和卟吩姆钠是常用的光敏剂,在医学的不同领域有着广泛应用。两者都有公认的安全性。它们最常用于湿性年龄相关性黄斑变性、胃肠道疾病和支气管癌。

结论

光动力疗法在眼科和其他医学领域是一种成熟的治疗方法。在眼科领域,它重新点燃了人们对常见但威胁视力的年龄相关性黄斑变性(AMD)问题的兴趣和希望。就治疗而言,这个问题仍然被认为是一个严重的问题。然而,在AMD的某些特定病例中,它已成功恢复视力,尤其是在该疾病的“典型”形式中。光动力疗法也正被用于治疗一系列实体癌和非恶性病症

相似文献

1
Review of photodynamic therapy.光动力疗法综述。
Surgeon. 2006 Aug;4(4):231-6. doi: 10.1016/s1479-666x(06)80065-x.
2
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管:两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法(TAP)研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
3
Photodynamic therapy with verteporfin: a new treatment in ophthalmology.维替泊芬光动力疗法:眼科的一种新治疗方法。
Semin Ophthalmol. 2001 Dec;16(4):201-6. doi: 10.1076/soph.16.4.201.10298.
4
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.维替泊芬光动力疗法治疗年龄相关性黄斑变性引起的脉络膜新生血管:1期和2期研究中的再次治疗结果
Arch Ophthalmol. 1999 Sep;117(9):1177-87. doi: 10.1001/archopht.117.9.1177.
5
Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.光动力疗法的实践:皇家维多利亚眼耳医院使用维替泊芬的前12个月经验结果综述
Clin Exp Ophthalmol. 2003 Dec;31(6):476-81. doi: 10.1046/j.1442-9071.2003.00714.x.
6
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada.在加拿大,与维替泊芬光动力疗法及标准治疗相比,培加他汀治疗中心凹下型湿性年龄相关性黄斑变性的成本效益。
Clin Ther. 2007 Sep;29(9):2096-106; discussion 2094-5. doi: 10.1016/j.clinthera.2007.09.001.
7
Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.维替泊芬(维速达尔)用于年龄相关性黄斑变性及其他病因所致脉络膜新生血管光动力治疗的指南:更新版
Retina. 2005 Feb-Mar;25(2):119-34. doi: 10.1097/00006982-200502000-00002.
8
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.维替泊芬:其在治疗黄斑中心凹下脉络膜新生血管中的应用综述
Drugs. 2003;63(22):2521-54. doi: 10.2165/00003495-200363220-00016.
9
Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology.维替泊芬光动力疗法治疗年龄相关性黄斑变性。美国眼科学会。
Ophthalmology. 2000 Dec;107(12):2314-7.
10
Verteporfin ocular photodynamic therapy.维替泊芬眼部光动力疗法
Expert Opin Pharmacother. 2004 Jan;5(1):195-203. doi: 10.1517/14656566.5.1.195.

引用本文的文献

1
Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration.当前和新型治疗方法治疗新生血管性年龄相关性黄斑变性。
Biomolecules. 2022 Nov 3;12(11):1629. doi: 10.3390/biom12111629.
2
Water soluble octa-imidazolium zinc phthalocyanine for nucleus/nucleolus cell fluorescence microscopy and photodynamic therapy.用于细胞核/核仁细胞荧光显微镜检查和光动力疗法的水溶性八咪唑锌酞菁
Photochem Photobiol Sci. 2023 Feb;22(2):303-309. doi: 10.1007/s43630-022-00313-0. Epub 2022 Oct 6.
3
Locked and Loaded: β-Galactosidase Activated Photodynamic Therapy Agent Enables Selective Imaging and Targeted Treatment of Glioblastoma Multiforme Cancer Cells.
准备就绪:β-半乳糖苷酶激活的光动力治疗剂可实现多形性胶质母细胞瘤癌细胞的选择性成像和靶向治疗。
ACS Appl Bio Mater. 2022 Aug 31;5(9):4284-93. doi: 10.1021/acsabm.2c00484.
4
Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.卟啉衍生物通过其电荷分布来调节 20S 蛋白酶体的活性。
Biomolecules. 2022 May 24;12(6):741. doi: 10.3390/biom12060741.
5
Activity-Based Photosensitizers with Optimized Triplet State Characteristics Toward Cancer Cell Selective and Image Guided Photodynamic Therapy.基于活性的光动力治疗敏化剂,具有优化的三重态特性,可实现对癌细胞的选择性和图像引导。
ACS Appl Bio Mater. 2022 Jun 20;5(6):2754-2767. doi: 10.1021/acsabm.2c00202. Epub 2022 May 10.
6
Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease.诱导多能干细胞和间充质干细胞治疗退行性视网膜疾病的现状、障碍及未来方向。
Int J Mol Sci. 2022 Feb 25;23(5):2529. doi: 10.3390/ijms23052529.
7
The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.TMPyP4和顺铂在骨肉瘤炎症微环境中的不同生物学效应归因于G-四链体。
Cell Prolif. 2021 Sep;54(9):e13101. doi: 10.1111/cpr.13101. Epub 2021 Jul 23.
8
HO enhances the anticancer activity of TMPyP4 by ROS-mediated mitochondrial dysfunction and DNA damage.HO 通过 ROS 介导的线粒体功能障碍和 DNA 损伤增强 TMPyP4 的抗癌活性。
Med Oncol. 2021 Apr 21;38(6):59. doi: 10.1007/s12032-021-01505-x.
9
Nanomaterial Applications in Photothermal Therapy for Cancer.纳米材料在癌症光热治疗中的应用
Materials (Basel). 2019 Mar 7;12(5):779. doi: 10.3390/ma12050779.
10
TMPyP4 promotes cancer cell migration at low doses, but induces cell death at high doses.TMPyP4在低剂量时促进癌细胞迁移,但在高剂量时诱导细胞死亡。
Sci Rep. 2016 May 25;6:26592. doi: 10.1038/srep26592.